Abstract
Food allergy is a common disorder in the Western world, with increasing prevalence and substantial healthcare costs(1). Food allergy is often accompanied by the presence of specific IgE against harmless proteins in food, but not all sensitized children show clinical reactions upon exposure. Therefore, double-blind placebo-controlled food challenges (DBPCFC) remain the gold standard to diagnose food allergy, yet this test is demanding. Biomarkers that can predict clinical response to food are urgently needed.
Original language | English |
---|---|
Pages (from-to) | 614-619 |
Number of pages | 6 |
Journal | Clinical and Experimental Allergy |
Volume | 51 |
Issue number | 4 |
Early online date | 5-Dec-2020 |
DOIs | |
Publication status | Published - Apr-2021 |